AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
155 hedge funds and large institutions have $716M invested in Aerie Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 54 increasing their positions, 47 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
49% less capital invested
Capital invested by funds: $1.39B → $716M (-$677M)
85% less call options, than puts
Call options by funds: $819K | Put options by funds: $5.37M
Holders
155
Holding in Top 10
6
Calls
$819K
Puts
$5.37M
Top Buyers
| 1 | +$10.3M | |
| 2 | +$6.84M | |
| 3 | +$6.79M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.68M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.46M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$21.8M | |
| 3 | -$19.2M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$17.2M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$13.9M |